TXG: 10x Genomics, Inc. Stock

SIC 3826 – Laboratory Analytical Instruments

Valuation
Market Cap ($M) 869.21
Enterprise Value ($M) 525.14
Book Value ($M) 710.13
Book Value / Share 6.56
Price / Book 1.22
NCAV ($M) 375.88
NCAV / Share 3.47
Price / NCAV 2.31

Profitability (mra)
Return on Invested Capital (ROIC) -0.23
Return on Assets (ROA) -0.20
Return on Equity (ROE) -0.25

Liquidity (mrq)
Quick Ratio 4.26
Current Ratio 4.97

Balance Sheet (mrq) ($M)
Current Assets 584.39
Assets 918.64
Liabilities 208.50
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 610.78
Operating Income -194.56
Net Income -182.63
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 6.66
Cash from Investing -32.63
Cash from Financing 10.91

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-04 13G Millennium Management Llc 5.10
11-08 13G Nikko Asset Management Americas, Inc. 5.98
11-05 13G Sumitomo Mitsui Trust Holdings, Inc. 5.98
10-04 13G/A Vanguard Group Inc 10.30 21.77
08-12 13G ARK Investment Management LLC 10.75
06-07 13G/A Baillie Gifford & Co 2.63 -64.94

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-10-29 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-30 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 1,428,881 5,500,870 25.98
2025-04-16 375,751 2,620,798 14.34
2025-04-15 353,812 2,743,712 12.90
2025-04-14 388,602 2,794,248 13.91

(click for more detail)

Similar Companies
SEER – Seer, Inc. TER – Teradyne, Inc.
TRMB – Trimble Inc.


Financial data and stock pages provided by
Fintel.io